Opendata, web and dolomites

Fertissimo SIGNED

A ground-breaking medical system selecting the most viable embryo for successful IVF pregnancy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Fertissimo project word cloud

Explore the words cloud of the Fertissimo project. It provides you a very rough idea of what is the project "Fertissimo" about.

diagnostics    fertissimo    clinics    carmel    chances    trial    procedure    equates    tools    conclusive    soon    unprecedented    outcomes    quantitative    qualities    mothers    stress    met    industrially    predict    hospitals    ivf    practiced    mass    company    benefit    ivi    engineering    forming    invasive    profile    retrospective    costly    clinical    media    efficient    prospective    physician    qualified    unable    located    gold    biomarker    conduct    lay    dependable    os    infrastructure    risk    accommodate    ultimate    forces    medical    riskier    line    multiple    aran    incubated    25    create    finances    rapid    joins    pregnancies    rates    minimise    foundation    qualify    low    accurate    oxidative    series    rate    excellence    certify    transfer    leader    standard    embryo    2009    solid    facilities    embryos    innovation    viability    reproductive    validation    basis    single    utilises    manner    morphology    valencia    pregnancy    centres    global    culture    legacy   

Project "Fertissimo" data sheet

The following table provides information about the project.

Coordinator
CARMEL DIAGNOSTICS LTD 

Organization address
address: 9 BARLEV HAIM STREET
city: QIRYAT TIVON
postcode: 3608267
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.fertissimoivf.com
 Total cost 2˙751˙973 €
 EC max contribution 2˙711˙973 € (99%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARMEL DIAGNOSTICS LTD IL (QIRYAT TIVON) coordinator 1˙446˙486.00
2    ARAN RESEARCH DEVELOPMENT & PROTOTYPES LTD IL (CAESAEA) participant 1˙265˙487.00

Map

 Project objective

Low rates of pregnancy in IVF procedure is due to being unable to identify viable embryos for transfer. As a result, multiple embryo transfer (MET) is practiced to increase the chances of pregnancy. This is a costly procedure with riskier outcomes, which on average only equates to a 1 out of 4 rate of pregnancy success. In order to minimise the cost and risk outcomes with MET, there are increasing trends have been adopted to accommodate single embryo transfer (SET). SET however, requires more efficient embryo selection tools than current legacy morphology methods.

Fertissimo utilises a novel biomarker of oxidative stress (OS) qualities that will enable the physician’s selection of viable embryos in a rapid, non-invasive, and accurate manner. Fertissimo will provide a quantitative assessment of an embryo’s reproductive potential based on the oxidative profile of its incubated culture media. It will increase IVF pregnancy outcomes by an unprecedented 25% and beyond.

The Phase 2 project’s ultimate aim is to lay the foundation for dependable IVF pregnancies of the future. Fertissimo will set the gold standard for IVF procedure in all relevant IVF facilities, located in hospitals, medical centres, centres of IVF excellence, and clinics. Carmel Diagnostics will conduct a series of clinical validation studies, both retrospective and prospective, in order to qualify the novel OS biomarker to effectively predict embryo viability

Carmel Diagnostics (established in 2009) joins forces with Aran R&D, a leading engineering and product development company, forming a solid basis with all necessary knowledge capabilities, infrastructure and finances to support the innovation project. This would allow Carmel, and Aran, to develop, test, certify, and create the production line required for Fertissimo’s mass production.

The industrially produced Fertissimo can then be qualified in a conclusive clinical trial with Global IVF Leader IVI Valencia to the benefit of soon-to-be mothers

 Deliverables

List of deliverables.
Original Investor Relations Kit Dossier Websites, patent fillings, videos etc. 2019-03-20 11:46:21
Project website Websites, patent fillings, videos etc. 2019-03-20 11:46:21

Take a look to the deliverables list in detail:  detailed list of Fertissimo deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FERTISSIMO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FERTISSIMO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

Read More